Nigel McMillan – Griffith News

Griffith researchers draw more than $9m NHMRC funding

Gold Coast Health and Knowledge Precinct

PublishedDecember 15, 2023December 18, 2023 AuthorCarley Rosengreen

Advanced bionic limb development, malaria drug mechanisms, skin immune response to mosquito-borne infections among new Ideas Grants.

Griffith University and Gene Company partner to create exciting RNA-based COVID anti-viral

SARS-CoV-2â€” the virus that causes COVID-19â€”isolated from a patient in the U.S. Virus particles are shown emerging from the surface of cells cultured in a lab. The spikes on the outer edge of the virus particles give coronaviruses their name, crown-like. Credit: NIAID-RML

17 Partnerships for the Goals

PublishedJuly 26, 2023July 27, 2023 AuthorEmma O'Connor

Griffith University has entered into a $135 million commercial partnership with Gene Company o further develop a new drug treatment for SARS-CoV-2, the virus responsible for COVID-19.

Researchers develop direct-acting antiviral therapy to treat COVID-19

The COVID-19 antiviral research team Professor Kevin Morris, Dr Adi Idris, Professor Nigel McMillan, Dr Arron Supramanin and Mr Yusif Idres.

Griffith Health

PublishedMay 17, 2021August 3, 2022 AuthorContributed

A team of international scientists has developed an an experimental direct-acting antiviral to treat COVID-19.

Griffith cancer research among the best

Griffith Health

PublishedFebruary 12, 2013 AuthorHamish Townsend

Griffith's cancer research has been acknowledged as among the best in the state by Cancer Council Queensland and rewarded with significant funding.

Silencing the Hendra virus by "stealth"

Griffith Health Institute

PublishedJune 4, 2012August 28, 2012 AuthorContributed

Associate Professor Nigel McMillan from Griffith University’s School of Medical Science has been awarded federal government funding to make further progress towards a human cure for the deadly Hendra virus. Since the first outbreak of the disease in 1994, there have been seven confirmed human cases in Australia, resulting in four deaths. Currently there are […]

GriffithNews

Tagged with Nigel McMillan

Griffith researchers draw more than $9m NHMRC funding

Griffith University and Gene Company partner to create exciting RNA-based COVID anti-viral

Researchers develop direct-acting antiviral therapy to treat COVID-19

Griffith cancer research among the best

Silencing the Hendra virus by "stealth"